Concomitant administration of meningococcal vaccines with other vaccines in adolescents and adults: a review of available evidence
- PMID: 30779683
- PMCID: PMC6773407
- DOI: 10.1080/21645515.2019.1581542
Concomitant administration of meningococcal vaccines with other vaccines in adolescents and adults: a review of available evidence
Abstract
Invasive meningococcal disease (IMD), a rapidly progressing and potentially fatal illness, disproportionately affects adolescents and young adults. While IMD is best prevented by vaccination, vaccine uptake in these groups is low. An evidence-based understanding of the safety and effectiveness of concomitant vaccination of meningococcal vaccines, including the newer MenB protein vaccines and the more established MenACWY conjugate vaccines, with other vaccines recommended for adolescents and young adults may help maximize vaccination opportunities. We identified 21 studies assessing concomitant administration of meningococcal vaccines with other vaccines in adolescents and adults. Although studies varied in methodology, concomitant administration generally did not affect immunogenicity of the meningococcal or coadministered vaccines. In some cases, reactogenicity increased following concomitant administration, but no definitive safety concerns were raised. In general, data suggest that meningococcal vaccines can be safely and effectively coadministered with other vaccines.
Keywords: Invasive meningococcal disease; MenB-FHbp; adolescents; adults; concomitant; vaccination.
Figures
Similar articles
-
Inequalities in the risk and prevention of invasive meningococcal disease in the United States - A systematic literature review.Hum Vaccin Immunother. 2024 Dec 31;20(1):2406613. doi: 10.1080/21645515.2024.2406613. Epub 2024 Oct 7. Hum Vaccin Immunother. 2024. PMID: 39373020 Free PMC article.
-
Meningococcal vaccination: a discussion with all adolescents, whether college-bound or not.Postgrad Med. 2019 Nov;131(8):551-554. doi: 10.1080/00325481.2019.1671667. Epub 2019 Oct 14. Postgrad Med. 2019. PMID: 31575310
-
Meningococcal Group A, C, W, and Y Tetanus Toxoid Conjugate Vaccine: A Review of Clinical Data in Adolescents.J Adolesc Health. 2018 Sep;63(3):269-279. doi: 10.1016/j.jadohealth.2018.05.012. J Adolesc Health. 2018. PMID: 30236996 Review.
-
Meningococcal Vaccination of Adolescents in the United States: Past Successes and Future Considerations.J Adolesc Health. 2024 Jun;74(6):1068-1077. doi: 10.1016/j.jadohealth.2024.01.016. Epub 2024 Mar 2. J Adolesc Health. 2024. PMID: 38430074 Review.
-
Concomitant administration of a fully liquid ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal ACWY conjugate vaccine in toddlers.Vaccine. 2018 Dec 18;36(52):8019-8027. doi: 10.1016/j.vaccine.2018.10.100. Epub 2018 Nov 22. Vaccine. 2018. PMID: 30471953 Clinical Trial.
Cited by
-
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix in Healthy Adolescents: A Randomized Phase IIIb Multicenter Study.Infect Dis Ther. 2024 Aug;13(8):1835-1859. doi: 10.1007/s40121-024-01009-x. Epub 2024 Jul 2. Infect Dis Ther. 2024. PMID: 38955966 Free PMC article.
-
Meningococcal Disease in Pediatric Age: A Focus on Epidemiology and Prevention.Int J Environ Res Public Health. 2022 Mar 29;19(7):4035. doi: 10.3390/ijerph19074035. Int J Environ Res Public Health. 2022. PMID: 35409716 Free PMC article.
-
Meningococcal B vaccine antigen FHbp variants among disease-causing Neisseria meningitidis B isolates, Italy, 2014-2017.PLoS One. 2020 Nov 11;15(11):e0241793. doi: 10.1371/journal.pone.0241793. eCollection 2020. PLoS One. 2020. PMID: 33176334 Free PMC article.
-
Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review.Hum Vaccin Immunother. 2023 Aug 1;19(2):2245705. doi: 10.1080/21645515.2023.2245705. Hum Vaccin Immunother. 2023. PMID: 37642229 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical